Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. VINGE ADVISES ON THE SALE OF BRÖDERNA NILSSON DELIKATESSER
Mandate

VINGE ADVISES ON THE SALE OF BRÖDERNA NILSSON DELIKATESSER

October 24, 2014

Vinge has advised the owner of Bröderna Nilsson Delikatesser in connection with the transfer of all shares to Scandza AS, which is owned by CapVest. Bröderna Nilsson Delikatesser is a premium supplier of various cured meats primarily to the large supermarket chains. The company has approximately 85 employees and its turnover in 2012/2013 was approximately SEK 225 million with an EBITDA of approximately SEK 30 million.

Vinge’s team primarily consisted of responsible partner Anders Strid together with associates Patrick Gargolinski and Daniel Lennartsson (M&A) as well as Anna Siesing (employment). Censor AB acted as the sellers’ financial adviser. 

Related

Vinge has advised Egetis Therapeutics in connection with a directed share issue

 Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of approximately SEK 183 million before transaction costs.
October 06, 2025

Vinge worked with funds advised by Agilitas on the buy-out of Vivicta (previously Tietoevry Tech Services), including on the issuance of senior secured bonds and on entering into a super senior RCF

 Vinge, together with O’Melveny as lead counsel and Avance, worked with funds advised by Agilitas Private Equity LLP (“Agilitas”), the pan-European mid-market private equity firm, in their backing of Vivicta. The buy-out was previously announced on 24 March 2025 and closed on 2 September 2025.
October 03, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 671.5 million

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of approx. SEK 671.5 million before transaction costs.
October 03, 2025